KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,548,000 | +194.3% | 150,000 | +200.0% | 0.43% | +184.0% |
| Q1 2021 | $526,000 | -66.0% | 50,000 | -50.0% | 0.15% | -67.4% |
| Q4 2020 | $1,548,000 | -39.4% | 100,000 | -42.9% | 0.46% | -41.1% |
| Q3 2020 | $2,555,000 | +79.8% | 175,000 | +133.3% | 0.78% | +83.3% |
| Q2 2020 | $1,421,000 | -26.0% | 75,000 | -25.0% | 0.43% | -49.6% |
| Q1 2020 | $1,921,000 | -71.0% | 100,000 | -71.0% | 0.85% | -67.1% |
| Q4 2019 | $6,614,000 | – | 345,000 | – | 2.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |